Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 18 stocks, with a combined market cap of $2,940.46 billion, total revenue of $603.35 billion and a weighted average PE ratio of 34.14.

Market Cap
2,940.46B
Revenue
603.35B
Profits
86.13B
PE Ratio
34.14
Profit Margin
14.28%
Dividend Yield
2.03%

18 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company747.99B3.19%2,713,46435.93B
2JNJJohnson & Johnson367.43B0.85%5,367,47681.80B
3MRKMerck & Co., Inc.333.65B2.39%7,223,23761.40B
4ABBVAbbVie Inc.289.23B1.36%5,260,52154.40B
5AZNAstraZeneca PLC238.64B-0.09%3,854,31847.61B
6NVSNovartis AG201.95B-0.09%1,052,86049.92B
7AMGNAmgen Inc.171.14B2.45%3,462,75929.53B
8PFEPfizer Inc.163.31B1.55%34,597,28255.09B
9SNYSanofi113.46B-0.99%4,252,60551.60B
10GSKGSK plc93.18B0.09%3,767,53639.41B
11BMYBristol-Myers Squibb Company90.31B-0.36%8,314,04945.53B
12GILDGilead Sciences, Inc.83.48B-0.95%7,529,15827.45B
13BIIBBiogen Inc.34.26B3.72%1,791,1349.66B
14GRFSGrifols, S.A.6.31B2.95%1,605,3287.32B
15OGNOrganon & Co.5.57B1.41%2,141,2566.35B
16AMRNAmarin Corporation plc384.41M2.87%555,423277.46M
17SCLXScilex Holding Company148.27M2.29%592,50147.05M
18MIRAMIRA Pharmaceuticals, Inc.10.41M-3.79%42,967-